These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 16917170)

  • 1. Recovery of subjective visual horizontal after unilateral vestibular deafferentation by intratympanic instillation of gentamicin.
    Takai Y; Murofushi T; Ushio M; Iwasaki S
    J Vestib Res; 2006; 16(1-2):69-73. PubMed ID: 16917170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy.
    Minor LB
    Am J Otol; 1999 Mar; 20(2):209-19. PubMed ID: 10100525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratympanic gentamicin for intractable Meniere's disease.
    Perez N; Martín E; García-Tapia R
    Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Ménière's disease by low-dosage intratympanic gentamicin application: effect on otolith function.
    Helling K; Schönfeld U; Clarke AH
    Laryngoscope; 2007 Dec; 117(12):2244-50. PubMed ID: 17909448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transtympanic gentamicin and fibrin tissue adhesive for treatment of unilateral Menière's disease: effects on vestibular function.
    Casani A; Nuti D; Franceschini SS; Gaudini E; Dallan I
    Otolaryngol Head Neck Surg; 2005 Dec; 133(6):929-35. PubMed ID: 16360516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable Ménière's disease.
    Horii A; Saika T; Uno A; Nishiike S; Mitani K; Nishimura M; Kitahara T; Fukushima M; Nakagawa A; Masumura C; Sasaki T; Kizawa K; Kubo T
    Otol Neurotol; 2006 Sep; 27(6):896-900. PubMed ID: 16788414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratympanic gentamicin therapy for vertigo in nonserviceable ears.
    Bauer PW; MacDonald CB; Cox LC
    Am J Otolaryngol; 2001; 22(2):111-5. PubMed ID: 11283825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratympanic gentamicin in Ménière's disease: results of therapy.
    Murofushi T; Halmagyi GM; Yavor RA
    Am J Otol; 1997 Jan; 18(1):52-7. PubMed ID: 8989952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does intratympanic gentamicin treatment for Meniere's disease cause complete vestibular ablation?
    Hone SW; Nedzelski J; Chen J
    J Otolaryngol; 2000 Apr; 29(2):83-7. PubMed ID: 10819105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Skull vibratory test in partial vestibular lesions--influence of the stimulus frequency on the nystagmus direction].
    Dumas G; Perrin P; Morel N; N'Guyen DQ; Schmerber S
    Rev Laryngol Otol Rhinol (Bord); 2005; 126(4):235-42. PubMed ID: 16496550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reliability of the vestibular evoked myogenic potential test in assessing intratympanic gentamicin therapy in Meniere's disease.
    Ozluoglu LN; Akkuzu G; Ozgirgin N; Tarhan E
    Acta Otolaryngol; 2008 Apr; 128(4):422-6. PubMed ID: 18368577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vestibular function at the end of intratympanic gentamicin treatment of patients with Ménière's disease.
    Perez N; Rama-Lopez J
    J Vestib Res; 2005; 15(1):49-58. PubMed ID: 15908740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Auditory results after vestibular nerve section and intratympanic gentamicin for Ménière's disease.
    Colletti V; Carner M; Colletti L
    Otol Neurotol; 2007 Feb; 28(2):145-51. PubMed ID: 17255880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intentional ablation of vestibular function using commercially available topical gentamicin-betamethasone eardrops in patients with Meniere's disease: further evidence for topical eardrop ototoxicity.
    Kaplan DM; Hehar SS; Bance ML; Rutka JA
    Laryngoscope; 2002 Apr; 112(4):689-95. PubMed ID: 12150525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratympanic gentamicin for the treatment of Meniere's disease and other forms of peripheral vertigo.
    Carey J
    Otolaryngol Clin North Am; 2004 Oct; 37(5):1075-90. PubMed ID: 15474112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intratympanic gentamicin treatment for intractable Menière's disease].
    Gilony D; Wolf M; Kronenberg J
    Harefuah; 2004 Jan; 143(1):4-7, 88. PubMed ID: 14748278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vestibular and audiologic functions in gentamicin-treated Menière's disease.
    Möller C; Odkvist LM; Thell J; Larsby B; Hydén D
    Am J Otol; 1988 Sep; 9(5):383-91. PubMed ID: 3202127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refractory episodic vertigo: role of intratympanic gentamicin and vestibular evoked myogenic potentials.
    Celis-Aguilar E; Hinojosa-González R; Vales-Hidalgo O; Coutinho-Toledo H
    Braz J Otorhinolaryngol; 2016; 82(6):668-673. PubMed ID: 27068887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-shot, low-dose intratympanic gentamicin in Ménière disease: role of vestibular-evoked myogenic potentials and caloric test in the prediction of outcome.
    Gode S; Celebisoy N; Akyuz A; Gulec F; Karapolat H; Bilgen C; Kirazli T
    Am J Otolaryngol; 2011; 32(5):412-6. PubMed ID: 20851502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hearing loss after intratympanic gentamicin therapy for unilateral Ménière's Disease.
    Martin E; Perez N
    Otol Neurotol; 2003 Sep; 24(5):800-6. PubMed ID: 14501459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.